JPMorgan initiated coverage of EssilorLuxottica with an Overweight rating and EUR 215 price target, which represents 26% upside potential. EssilorLuxottica is the "unrivalled" global player in eyecare, focused on growing awareness of vision correction needs, while leading innovation in new fields and technologies, the analyst tells investors in a research note. The firm views the current trading levels as an attractive entry point.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ESLOY: